
Although virtual meetings have become more widespread, also when selling medicine, Danish pharmaceutical company Novo Nordisk's experience with launching diabetes tablet Rybelsus has shown that they are not sufficient, according to Danish newspaper Børsen.
Novo Nordisk CEO & President Lars Fruergaard Jørgensen is dubious about the notion that physical salespeople might be replaced by digital communications with physicians.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app